SCHEMBL3346124

SCHEMBL3346124

Cc1cc(-c2ccc(C)c(C(N)=O)c2)ccn1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CB P42338 1/20 0.67
CCNC P24863 2/20 0.56
CDK8 P49336 2/20 0.56
CHUK O15111 1/20 0.47
DYRK1A Q13627 1/20 0.46
MKNK1 Q9BUB5 2/20 0.46
MKNK2 Q9HBH9 2/20 0.46
SIRT3 Q9NTG7 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PIK3R2 O00459 1/20 0.43
MAP4K4 O95819 1/20 0.43
PSEN1 P49768 3/20 0.42
PSEN2 P49810 3/20 0.42
APH1B Q8WW43 3/20 0.42
NCSTN Q92542 3/20 0.42
APH1A Q96BI3 3/20 0.42
PSENEN Q9NZ42 3/20 0.42
WNT3A P56704 2/20 0.42
PORCN Q9H237 1/20 0.42
PKMYT1 Q99640 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21923189 0.84 PIK3CB (0.51) PIK3CBCCNCCDK8DYRK1AMKNK2
SCHEMBL3342702 0.83 CHUK (0.68) CCNCCDK8CHUKDYRK1AMKNK1
SCHEMBL3346810 0.81 MKNK1 (0.52) PIK3CBCHUKMKNK1MKNK2SIRT3
SCHEMBL3342661 0.80 TGFBR1 (0.46) PIK3CBCCNCCDK8CHUKMKNK1
SCHEMBL11153504 0.79 PIK3CB (0.72) PIK3CBCCNCCDK8CHUKPIK3R2
SCHEMBL3342287 0.79 MKNK2 (0.47) PIK3CBCHUKMKNK1MKNK2SIRT3
SCHEMBL25307513 0.77 PIK3CB (0.58) PIK3CBCCNCCDK8CHUKDYRK1A
SCHEMBL3342234 0.77 KMO (0.47) PIK3CBMKNK1MKNK2SIRT3TDP1
SCHEMBL10320333 0.77 BRD4 (0.46) PIK3CBCHUKMKNK1MKNK2SIRT3
SCHEMBL29695035 0.76 PIK3CB (0.61) PIK3CBCCNCCDK8DYRK1ASIRT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 PIK3CB 3229/4885CCNC 3113/4885CDK8 2497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.